Does LURBINECTEDIN Cause Infusion site extravasation? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Infusion site extravasation have been filed in association with LURBINECTEDIN (ZEPZELCA). This represents 0.8% of all adverse event reports for LURBINECTEDIN.
8
Reports of Infusion site extravasation with LURBINECTEDIN
0.8%
of all LURBINECTEDIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Infusion site extravasation From LURBINECTEDIN?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LURBINECTEDIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LURBINECTEDIN Cause?
Death (129)
Disease progression (98)
Off label use (69)
Neutropenia (59)
Nausea (58)
Thrombocytopenia (48)
Fatigue (43)
Febrile neutropenia (39)
Vomiting (37)
Asthenia (36)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which LURBINECTEDIN Alternatives Have Lower Infusion site extravasation Risk?
LURBINECTEDIN vs LUSPATERCEPT
LURBINECTEDIN vs LUSPATERCEPT-AAMT
LURBINECTEDIN vs LUTEIN
LURBINECTEDIN vs LUTETIUM LU-177
LURBINECTEDIN vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN